138267 (COM.TO) (TSE:COM) and Amplia Therapeutics (ASX:ATX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.
Earnings & Valuation
This table compares 138267 (COM.TO) and Amplia Therapeutics' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
138267 (COM.TO) | N/A | N/A | N/A | N/A | N/A |
Amplia Therapeutics | $894,155.00 | 0.00 | $-3,023,244.00 | A($0.03) | N/A |
138267 (COM.TO) has higher earnings, but lower revenue than Amplia Therapeutics.
Profitability
This table compares 138267 (COM.TO) and Amplia Therapeutics' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
138267 (COM.TO) | N/A | N/A | N/A |
Amplia Therapeutics | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of recent ratings and price targets for 138267 (COM.TO) and Amplia Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
138267 (COM.TO) | 0 | 0 | 0 | 0 | N/A |
Amplia Therapeutics | 0 | 0 | 0 | 0 | N/A |
Summary
Amplia Therapeutics beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.